CARLA HOLMES: Open Payments
NPI 1356850887 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,237 in 136 payments from 41 companies in 2025. Trend: 2023 $958 · 2024 $1,520 · 2025 $3,237
Food & beverage: $2,859Education: $378
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 13 | $320 |
| AstraZeneca Pharmaceuticals LP | 10 | $266 |
| Novartis Pharmaceuticals Corporation | 9 | $234 |
| E.R. Squibb & Sons, L.L.C. | 7 | $198 |
| Janssen Biotech, Inc. | 8 | $192 |
| Incyte Corporation | 6 | $174 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $165 |
| Eisai Inc. | 7 | $156 |
| Astellas Pharma US Inc | 4 | $149 |
| Celgene Corporation | 6 | $120 |
Products named: Enhertu, Nubeqa, Lenvima, TECVAYLI, KISQALI, OPDUALAG, SCEMBLIX, PADCEV.
Industry payments across SC — which companies pay providers there.
